GlassScriptPhysician profile
Lido S Chen
NPI 1891781753
$1,598.22
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $890 · 2020: $708.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $319.87 | 2019-2020 | |
| Stimwave Technologies Incorporated | $220.43 | 2019 | |
| Scilex Pharmaceuticals INC. | $183.01 | 2019-2020 | |
| Nevro Corp. | $171.79 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $168.18 | 2019-2020 | |
| Abbott Laboratories | $68.47 | 2020 | |
| Pacira Therapeutics, INC. | $63.00 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $60.77 | 2019-2020 | |
| Sentynl Therapeutics, INC. | $46.35 | 2019-2020 | |
| Redhill Biopharma INC. | $43.12 | 2020 | |
| Arbor Pharmaceuticals, INC. | $28.75 | 2019-2020 | |
| Shionogi INC | $26.49 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $25.38 | 2019-2020 | |
| Biogen, INC. | $24.53 | 2019 | |
| Medtronic USA, INC. | $23.55 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $21.20 | 2020 | |
| Lilly USA, LLC | $21.17 | 2019 | |
| Ibsa Pharma INC. | $20.25 | 2020 | |
| Depuy Synthes Sales INC. | $18.83 | 2019 | |
| Assertio Therapeutics, INC. | $16.16 | 2019 | |
| Pfizer INC. | $15.20 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.72 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lido Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.